Genetic screen not worth cost for node-negative breast cancer patients
Posted on: 10/10/2014 - 18:27
Using a 70-gene signature screening tool for adjuvant chemotherapy decisions cost significantly more than did other methods, including giving chemotherapy to all patients, but did not confer any...
Field of Interest: Oncology
Type: News Item